Keyphrases
Malignancy
100%
Molecular Determinants
100%
Melanoma
100%
Chemotherapy Efficacy
100%
Nuclear factor-B
100%
Improved Efficacy
100%
Temozolomide
80%
BMS-345541
80%
Melanoma Cells
60%
BRAF V600E mutation
40%
In Vivo Antitumor Activity
40%
NF-B
40%
Extracellular Signal-regulated Kinase
40%
B-Raf
40%
Antitumor Activity
20%
Xenograft
20%
Drug Response
20%
Phosphorylation
20%
Drug Target
20%
Nuclear Localization
20%
Kinase Activity
20%
Mitogen-activated Protein Kinase
20%
C-Jun
20%
Activator protein-1 (AP-1)
20%
Death Pathway
20%
Protein Signaling
20%
Mitogen-activated Protein Kinase/extracellular Signal-regulated Kinase
20%
Human Melanoma
20%
Signaling Cascades
20%
Apoptotic Genes
20%
DNA Alkylating Agent
20%
Melanoma Treatment
20%
Human Metastatic Melanoma
20%
Anti-melanoma
20%
Advanced Metastatic Melanoma
20%
Kinase Activators
20%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Melanoma
100%
Alternative Complement Pathway C3 C5 Convertase
100%
Nuclear Factor
100%
Temozolomide
80%
Mitogen Activated Protein Kinase
60%
Antitumor Activity
40%
Metastatic Melanoma
40%
Phosphotransferase
40%
Drug Delivery System
20%
Antiapoptotic
20%
Protein P53
20%
Phosphotransferase Activator
20%
Alkylating Agent
20%
Mitogen Activated Protein Kinase Kinase
20%